Ongoing Support & Monitoring
Neurological Applications Both peptides have demonstrated some therapeutic potential in neurological applications, though this represents a less extensively studied area
For some patients, objective testing may be a useful part of that process
GLP1 also decreases both the release and breakdown of stored carbohydrates as well as the synthesis of new glucose by inhibiting the production of glucagon which is a hormone responsible for increasing glucose levels in the body
After gaining extra pounds, the body often adjusts to a higher set point and: Increases hunger Decreases satisfaction Slows metabolism Even with healthy habits, that can make long-term weight loss extremely challenging
An additional annual weight loss of 4.8% total body weight (mean 4.4 kg) has been observed, with side effects including nausea, headache and dizziness [11, 16]